ArticleTreat-to-Target Outcomes With Tapinarof Cream 1% in Phase 3 Trials for Plaque PsoriasisAuthor:April W. Armstrong, MD, MPHPublish date: October 4, 2024 The National Psoriasis Foundation (NPF) treatment targets aim to achieve 1% or lower body surface area (BSA) affected...Read More
ArticleBrodalumab in an Organ Transplant Recipient With PsoriasisAuthor:April W. Armstrong, MD, MPHPublish date: February 3, 2021Reports of brodalumab use for psoriasis in organ transplant recipients are limited. We report a case in which brodalumab was used to treat psoriasi...Read More
